الصفحة الرئيسية>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Imipenem (hydrate)

Imipenem (hydrate) (Synonyms: NFormimidoyl Thienamycin)

رقم الكتالوجGC43898

Imipenem (hydrate) ، مشتق بلوري مستقر من thienamycin ، هو مضاد حيوي وله نشاط ممتاز ضد مجموعة واسعة من البكتيريا الهوائية واللاهوائية موجبة الجرام وسالبة الجرام.

Products are for research use only. Not for human use. We do not sell to patients.

Imipenem (hydrate) التركيب الكيميائي

Cas No.: 74431-23-5

الحجم السعر المخزون الكميّة
5mg
59٫00
متوفر
10mg
81٫00
متوفر
25mg
114٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Video Related Products

Imipenem monohydrate, a member of the carbapenem class of antibiotics isolated from the soil organism Streptomyces cattleya[1], is an intravenous β-lactam antibiotic effective against a wide range of Gram-positive and Gram-negative bacteria, including several multi-drug resistant bacterial species. Imipenem acts as cell wall-targeting antibiotic[2][3].

References:
[1]. Zhanel GG, et al. Imipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects. Can J Infect Dis. 1998 Jul;9(4):215-28.
[2]. Jacoby GA, et al. AmpC beta-lactamases. Clin Microbiol Rev. 2009 Jan;22(1):161-82.
[3]. Balibar CJ, et al. cwrA, a gene that specifically responds to cell wall damage in Staphylococcus aureus. Microbiology. 2010 May;156(Pt 5):1372-83.

مراجعات

Review for Imipenem (hydrate)

Average Rating: 5 ★★★★★ (Based on Reviews and 11 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Imipenem (hydrate)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.